Ascendis Pharma A/S (ASND) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$221.05
+2.53%
Mkt Cap $14.73B
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 11, 2026 | $292.26M | $344.84M | +17.99% | -$0.06 | -$0.64 | -966.67% |
| Q4 2025 Nov 12, 2025 | $302.60M | $250.22M | -17.31% | -$0.41 | -$1.17 | -185.37% |
| Q3 2025 Aug 7, 2025 | $233.12M | $186.09M | -20.17% | -$1.42 | -$0.93 | +34.51% |
| Q2 2025 May 1, 2025 | $153.48M | $110.67M | -27.89% | -$1.56 | -$1.66 | -6.41% |
| Q1 2025 Feb 12, 2025 | $125.42M | $180.09M | +43.59% | -$1.20 | -$0.68 | +43.33% |
| Q4 2024 Nov 14, 2024 | $74.14M | $63.43M | -14.45% | -$1.83 | -$1.81 | +1.15% |
| Q3 2024 Sep 3, 2024 | $37.58M | $38.71M | +3.01% | -$1.54 | -$2.05 | -33.12% |
| Q2 2024 May 2, 2024 | $92.36M | $103.02M | +11.54% | -$1.62 | -$2.48 | -53.33% |
| Q1 2024 Feb 7, 2024 | $111.12M | $151.44M | +36.28% | -$2.19 | -$1.66 | +24.14% |
| Q4 2023 Nov 7, 2023 | $55.32M | $50.67M | -8.41% | -$2.55 | -$3.08 | -21.01% |
| Q3 2023 Aug 16, 2023 | — | $51.70M | — | -$3.09 | -$1.54 | +50.19% |
| Q2 2023 Apr 27, 2023 | $25.78M | $36.52M | +41.63% | -$2.93 | -$2.18 | +25.56% |
| Q1 2023 Feb 16, 2023 | $22.05M | $24.66M | +11.86% | -$2.74 | -$3.96 | -44.53% |
| Q4 2022 Nov 2, 2022 | $13.60M | $14.93M | +9.82% | -$2.52 | -$3.05 | -21.03% |
| Q3 2022 Aug 10, 2022 | $6.01M | $6.44M | +7.27% | -$2.19 | -$1.50 | +31.46% |
| Q2 2022 May 11, 2022 | $5.25M | $7.55M | +43.76% | -$2.09 | -$2.31 | -10.50% |
| Q1 2022 Mar 2, 2022 | $3.38M | $5.55M | +64.20% | -$2.57 | -$2.06 | +20.09% |
| Q4 2021 Nov 10, 2021 | $1.70M | $1.29M | -24.14% | -$2.63 | -$1.69 | +35.81% |
| Q3 2021 Aug 25, 2021 | $1.30M | $1.21M | -7.03% | -$2.75 | -$3.01 | -9.45% |
| Q2 2021 May 27, 2021 | $1.19M | $877.43K | -26.55% | -$2.09 | -$1.43 | +31.58% |
| Q4 2020 Dec 31, 2020 | — | $656.11K | — | — | -$3.17 | — |
| Q4 2020 Nov 11, 2020 | $2.84M | $3.24M | +13.94% | -$1.87 | -$2.73 | -46.20% |
| Q3 2020 Aug 27, 2020 | $1.24M | $1.62M | +29.82% | -$1.71 | -$2.34 | -36.81% |
| Q2 2020 May 19, 2020 | $2.49M | $2.42M | -2.68% | -$1.48 | -$1.44 | +2.22% |
| Q2 2020 Apr 1, 2020 | $2.08M | $2.84M | +36.79% | -$1.59 | -$1.85 | -16.44% |
| Q4 2019 Nov 18, 2019 | $5.57M | $2.46M | -55.82% | -$1.32 | -$0.59 | +55.46% |
| Q3 2019 Aug 28, 2019 | $3.43M | $3.65M | +6.25% | -$1.34 | -$1.38 | -3.31% |
| Q2 2019 May 30, 2019 | $4.87M | $6.08M | +24.79% | -$1.12 | -$1.38 | -24.00% |
| Q2 2019 Apr 3, 2019 | $8.00M | $12.56M | +57.11% | -$1.12 | -$0.85 | +24.00% |
| Q4 2018 Nov 28, 2018 | $29.99K | $23.32K | -22.24% | -$1.21 | -$0.92 | +24.30% |
| Q3 2018 Aug 29, 2018 | $29.15K | $20.89K | -28.32% | -$1.05 | -$0.64 | +38.89% |
| Q2 2018 May 30, 2018 | $29.88K | $34.50K | +15.46% | -$0.90 | -$1.25 | -38.96% |
| Q1 2018 Mar 28, 2018 | — | $328.53K | — | -$0.99 | -$1.13 | -15.00% |
| Q4 2017 Nov 16, 2017 | $485.16K | $511.01K | +5.33% | -$0.87 | -$1.22 | -40.54% |
| Q3 2017 Aug 18, 2017 | $362.34K | $505.96K | +39.64% | -$0.85 | -$1.10 | -30.55% |
| Q2 2017 May 23, 2017 | $348.02K | $398.43K | +14.48% | -$0.84 | -$0.93 | -10.67% |
| Q1 2017 Mar 22, 2017 | — | $1.09M | — | -$0.61 | -$0.55 | +9.84% |
| Q4 2016 Nov 30, 2016 | $1.11M | $1.31M | +18.12% | -$0.73 | -$0.85 | -17.65% |
| Q3 2016 Aug 31, 2016 | $1.43M | $1.26M | -11.83% | -$0.77 | -$0.67 | +13.04% |
| Q2 2016 May 19, 2016 | $1.12M | $1.43M | +27.53% | -$0.65 | -$1.01 | -55.17% |
| Q4 2015 Dec 31, 2015 | — | $2.16M | — | — | -$0.52 | — |
| Q4 2015 Nov 12, 2015 | $3.04M | $2.37M | -21.94% | -$0.65 | -$0.35 | +45.00% |
| Q3 2015 Aug 24, 2015 | $1.94M | $2.15M | +11.34% | -$0.55 | -$0.79 | -42.86% |
| Q2 2015 May 18, 2015 | $4.52M | $2.26M | -50.03% | -$0.43 | $0.08 | +117.95% |
| Q1 2015 Mar 25, 2015 | — | $3.67M | — | — | -$0.71 | — |
| Q3 2014 Sep 30, 2014 | — | $4.10M | — | — | -$0.15 | — |
| Q2 2014 Jun 30, 2014 | — | $5.33M | — | — | -$0.27 | — |
| Q1 2014 Mar 31, 2014 | — | $5.49M | — | — | -$0.06 | — |
| Q4 2013 Dec 31, 2013 | — | $7.38M | — | — | $0.28 | — |
| Q3 2013 Sep 30, 2013 | — | $8.24M | — | — | $0.09 | — |
| Q2 2013 Jun 30, 2013 | — | $5.72M | — | — | $0.07 | — |
| Q1 2013 Mar 31, 2013 | — | $5.63M | — | — | $0.07 | — |